Saputo boosts whey, cheese and M&A in protein growth push

Whey is no longer just the stream that falls off after cheese gets made. Saputo is treating it as a profit engine, pushing harder into premium ingredients, bolt-on acquisitions and cheese marketing in a bid to turn protein demand into steadier earnings and less commodity exposure.

The June 8 growth plan centered on a 35% increase in WPC80 production, a premium whey ingredient prized in sports nutrition, active nutrition and functional foods. Saputo also plans to lift cheese marketing by 20% and expand further into cultured dairy and value-added drinks, signaling a broader effort to own more protein-led occasions across dairy and beverage channels. The strategy reaches beyond bulk milk solids and toward higher-value streams that can feed protein beverages, bars and reformulated foods.

That shift fits Saputo’s position as a top-10 global dairy processor with leading market positions in Canada, the United States, Australia, Argentina and the United Kingdom. The company says its products are sold in more than 60 countries, and its Canada and U.S. ingredient portfolios already include whey powder, whey protein concentrates, lactose and dairy ingredient blends. Saputo is already active in dairy alternative cheeses and beverages as well, giving management more room to link cheese, whey and adjacent categories into one portfolio built around protein and value-added nutrition.

The timing matters. Saputo reported fiscal 2026 results on June 4 for the year ended March 31, 2026, then held its fiscal 2026 results webcast and conference call on June 5, with a Q4 FY26 presentation in hand. For the fourth quarter, revenue fell 6% year over year to C$4.2 billion because of lower U.S. dairy commodity pricing, but adjusted EBITDA rose 5% to C$386 million and margin expanded to 9.2%. That spread between softer sales and better profitability is the clearest sign of what management is trying to build: a mix that holds up even when commodity pricing weakens.

Saputo’s investor materials point to strategic M&A in protein, better-for-you offerings and tailored nutrition, backed by disciplined capital allocation, organic growth and operational efficiency gains in the U.S. and Europe. The company’s June 8 plan looks less like a new direction than the next step in that portfolio shift, with bolt-on deals used where they fit logistics and market routes. The bet is straightforward: the next phase of dairy value creation will come less from volume and more from differentiated whey, cheese and ingredient assets that can weather commodity swings.